Back to results
US 5,851,774 AGranted
Human MLF3 protein
AssigneeIncyte Pharmaceuticals, Inc.
InventorsJennifer L. Hillman, Surya K. Goli
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeIncyte Pharmaceuticals, Inc.
InventorsJennifer L. Hillman, Surya K. Goli
Estimating the term…
The present invention provides a novel human integral membrane (MLF3) and polynucleotides which identify and encode MLF3. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding MLF3 and a method for producing MLF3. The invention also provides for agonists, antibodies, or antagonists specifically binding MLF3, and their use, in the prevention and treatment of diseases associated with expression of MLF3. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding MLF3 for the treatment of diseases associated with the expression of MLF3. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding MLF3.
An isolated and purified polynucleotide sequence encoding the polypeptide comprising the amino acid sequence of SEQ ID NO:1.
An isolated and purified polynucleotide sequence comprising SEQ ID NO:2.
An isolated and purified polynucleotide sequence which is complementary to SEQ ID NO:2.
Dependencies are inferred from the claim text.